{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T13:51:03Z","timestamp":1791294663501,"version":"4.1.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2016,6,3]],"date-time":"2016-06-03T00:00:00Z","timestamp":1464912000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virchows Arch"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1007\/s00428-016-1965-2","type":"journal-article","created":{"date-parts":[[2016,6,3]],"date-time":"2016-06-03T08:11:07Z","timestamp":1464941467000},"page":"233-241","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":52,"title":["Somatic mutations in histiocytic sarcoma identified by next generation sequencing"],"prefix":"10.1007","volume":"469","author":[{"given":"Qingqing","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith","family":"Tomaszewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lloyd","family":"Hutchinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason L.","family":"Hornick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce","family":"Woda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongbo","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,6,3]]},"reference":[{"key":"1965_CR1","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1097\/01.pas.0000131541.95394.23","volume":"28","author":"JL Hornick","year":"2004","unstructured":"Hornick JL, Jaffe ES, Fletcher CDM (2004) Extranodal histiocytic sarcoma\u2014clinicopathologic analysis of 14 cases of a rare epithelioid malignancy. Am J Surg Pathol 28:1133\u20131144. doi: 10.1097\/01.pas.0000131541.95394.23","journal-title":"Am J Surg Pathol"},{"key":"1965_CR2","volume-title":"WHO classification of tumours of haematopoietic and lymphoid tissue","author":"H Steven","year":"2008","unstructured":"Steven H, Swerdlow EC, Nancy LH, et al. (2008) WHO classification of tumours of haematopoietic and lymphoid tissue. IARC, Lyon"},{"key":"1965_CR3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3960\/jslrt.53.1","volume":"53","author":"E Takahashi","year":"2013","unstructured":"Takahashi E, Nakamura S (2013) Histiocytic sarcoma: an updated literature review based on the 2008 WHO classification. J Clin Exp Hematop: JCEH 53:1\u20138","journal-title":"J Clin Exp Hematop: JCEH"},{"key":"1965_CR4","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/00000478-199201000-00002","volume":"16","author":"S Milchgrub","year":"1992","unstructured":"Milchgrub S, Kamel OW, Wiley E, Vuitch F, Cleary ML, Warnke RA (1992) Malignant histiocytic neoplasms of the small intestine. Am J Surg Pathol 16:11\u201320","journal-title":"Am J Surg Pathol"},{"key":"1965_CR5","doi-asserted-by":"crossref","first-page":"241","DOI":"10.3109\/01913129409016296","volume":"18","author":"BM Osborne","year":"1994","unstructured":"Osborne BM, Mackay B (1994) True histiocytic lymphoma with multiple skin nodules. Ultrastruct Pathol 18:241\u2013246","journal-title":"Ultrastruct Pathol"},{"key":"1965_CR6","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.1002\/pbc.25100","volume":"61","author":"JL Heath","year":"2014","unstructured":"Heath JL, Burgett SE, Gaca AM, Jaffe R, Wechsler DS (2014) Successful treatment of pediatric histiocytic sarcoma using abbreviated high-risk leukemia chemotherapy. Pediatr Blood Cancer 61:1874\u20131876. doi: 10.1002\/pbc.25100","journal-title":"Pediatr Blood Cancer"},{"key":"1965_CR7","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1007\/s12185-014-1630-y","volume":"100","author":"H Tsujimura","year":"2014","unstructured":"Tsujimura H, Miyaki T, Yamada S, Sugawara T, Ise M, Iwata S, Yonemoto T, Ikebe D, Itami M, Kumagai K (2014) Successful treatment of histiocytic sarcoma with induction chemotherapy consisting of dose-escalated CHOP plus etoposide and upfront consolidation auto-transplantation. Int J Hematol 100:507\u2013510. doi: 10.1007\/s12185-014-1630-y","journal-title":"Int J Hematol"},{"key":"1965_CR8","doi-asserted-by":"publisher","first-page":"e251","DOI":"10.1200\/JCO.2010.32.6603","volume":"29","author":"U Gergis","year":"2011","unstructured":"Gergis U, Dax H, Ritchie E, Marcus R, Wissa U, Orazi A (2011) Autologous hematopoietic stem-cell transplantation in combination with thalidomide as treatment for histiocytic sarcoma: a case report and review of the literature. J Clin Oncol 29:e251\u2013e253. doi: 10.1200\/JCO.2010.32.6603","journal-title":"J Clin Oncol"},{"key":"1965_CR9","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1002\/ajh.20913","volume":"82","author":"MH Abidi","year":"2007","unstructured":"Abidi MH, Tove I, Ibrahim RB, Maria D, Peres E (2007) Thalidomide for the treatment of histiocytic sarcoma after hematopoietic stem cell transplant. Am J Hematol 82:932\u2013933. doi: 10.1002\/ajh.20913","journal-title":"Am J Hematol"},{"key":"1965_CR10","doi-asserted-by":"publisher","first-page":"3719","DOI":"10.1002\/cncr.26712","volume":"118","author":"N Shukla","year":"2012","unstructured":"Shukla N, Kobos R, Renaud T, Teruya-Feldstein J, Price A, McAllister-Lucas L, Steinherz P (2012) Successful treatment of refractory metastatic histiocytic sarcoma with alemtuzumab. Cancer 118:3719\u20133724. doi: 10.1002\/cncr.26712","journal-title":"Cancer"},{"key":"1965_CR11","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/S0092-8674(04)00215-6","volume":"116","author":"PT Wan","year":"2004","unstructured":"Wan PT, Garnett MJ, Roe SM, Lee S, Niculescu-Duvaz D, Good VM, Jones CM, Marshall CJ, Springer CJ, Barford D, Marais R, Cancer Genome P (2004) Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF. Cell 116:855\u2013867","journal-title":"Cell"},{"key":"1965_CR12","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1016\/j.ccr.2013.03.033","volume":"23","author":"M Holderfield","year":"2013","unstructured":"Holderfield M, Merritt H, Chan J, Wallroth M, Tandeske L, Zhai H, Tellew J, Hardy S, Hekmat-Nejad M, Stuart DD, McCormick F, Nagel TE (2013) RAF inhibitors activate the MAPK pathway by relieving inhibitory autophosphorylation. Cancer Cell 23:594\u2013602. doi: 10.1016\/j.ccr.2013.03.033","journal-title":"Cancer Cell"},{"key":"1965_CR13","doi-asserted-by":"publisher","first-page":"4532","DOI":"10.1158\/1078-0432.CCR-13-0657","volume":"19","author":"S Cardarella","year":"2013","unstructured":"Cardarella S, Ogino A, Nishino M, Butaney M, Shen J, Lydon C, Yeap BY, Sholl LM, Johnson BE, Janne PA (2013) Clinical, pathologic, and biologic features associated with BRAF mutations in non-small cell lung cancer. Clin Cancer Res 19:4532\u20134540. doi: 10.1158\/1078-0432.CCR-13-0657","journal-title":"Clin Cancer Res"},{"key":"1965_CR14","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.18632\/oncotarget.1840","volume":"5","author":"GM Wright","year":"2014","unstructured":"Wright GM, Do H, Weiss J, Alam NZ, Rathi V, Walkiewicz M, John T, Russell PA, Dobrovic A (2014) Mapping of actionable mutations to histological subtype domains in lung adenocarcinoma: implications for precision medicine. Oncotarget 5:2107\u20132115. doi: 10.18632\/oncotarget.1840","journal-title":"Oncotarget"},{"key":"1965_CR15","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s10549-012-2035-3","volume":"134","author":"L Santarpia","year":"2012","unstructured":"Santarpia L, Qi Y, Stemke-Hale K, Wang B, Young EJ, Booser DJ, Holmes FA, O\u2019Shaughnessy J, Hellerstedt B, Pippen J, Vidaurre T, Gomez H, Valero V, Hortobagyi GN, Symmans WF, Bottai G, Di Leo A, Gonzalez-Angulo AM, Pusztai L (2012) Mutation profiling identifies numerous rare drug targets and distinct mutation patterns in different clinical subtypes of breast cancers. Breast Cancer Res Treat 134:333\u2013343. doi: 10.1007\/s10549-012-2035-3","journal-title":"Breast Cancer Res Treat"},{"key":"1965_CR16","doi-asserted-by":"publisher","first-page":"9217","DOI":"10.1038\/sj.onc.1206909","volume":"22","author":"R Kumar","year":"2003","unstructured":"Kumar R, Angelini S, Hemminki K (2003) Activating BRAF and N-Ras mutations in sporadic primary melanomas: an inverse association with allelic loss on chromosome 9. Oncogene 22:9217\u20139224. doi: 10.1038\/sj.onc.1206909","journal-title":"Oncogene"},{"key":"1965_CR17","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1038\/nature10166","volume":"474","author":"Cancer Genome Atlas Research N","year":"2011","unstructured":"Cancer Genome Atlas Research N (2011) Integrated genomic analyses of ovarian carcinoma. Nature 474:609\u2013615. doi: 10.1038\/nature10166","journal-title":"Nature"},{"key":"1965_CR18","doi-asserted-by":"publisher","first-page":"2560","DOI":"10.1158\/1078-0432.CCR-07-1802","volume":"14","author":"Y Suehiro","year":"2008","unstructured":"Suehiro Y, Wong CW, Chirieac LR, Kondo Y, Shen L, Webb CR, Chan YW, Chan AS, Chan TL, Wu TT, Rashid A, Hamanaka Y, Hinoda Y, Shannon RL, Wang X, Morris J, Issa JP, Yuen ST, Leung SY, Hamilton SR (2008) Epigenetic-genetic interactions in the APC\/WNT, RAS\/RAF, and P53 pathways in colorectal carcinoma. Clin Cancer Res 14:2560\u20132569. doi: 10.1158\/1078-0432.CCR-07-1802","journal-title":"Clin Cancer Res"},{"key":"1965_CR19","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1038\/sj.bjc.6605371","volume":"101","author":"RE Board","year":"2009","unstructured":"Board RE, Ellison G, Orr MC, Kemsley KR, McWalter G, Blockley LY, Dearden SP, Morris C, Ranson M, Cantarini MV, Dive C, Hughes A (2009) Detection of BRAF mutations in the tumour and serum of patients enrolled in the AZD6244 (ARRY-142886) advanced melanoma phase II study. Br J Cancer 101:1724\u20131730. doi: 10.1038\/sj.bjc.6605371","journal-title":"Br J Cancer"},{"key":"1965_CR20","doi-asserted-by":"publisher","first-page":"2700","DOI":"10.1182\/blood-2012-05-430140","volume":"120","author":"J Haroche","year":"2012","unstructured":"Haroche J, Charlotte F, Arnaud L, von Deimling A, Helias-Rodzewicz Z, Hervier B, Cohen-Aubart F, Launay D, Lesot A, Mokhtari K, Canioni D, Galmiche L, Rose C, Schmalzing M, Croockewit S, Kambouchner M, Copin MC, Fraitag S, Sahm F, Brousse N, Amoura Z, Donadieu J, Emile JF (2012) High prevalence of BRAF V600E mutations in Erdheim-Chester disease but not in other non-Langerhans cell histiocytoses. Blood 120:2700\u20132703. doi: 10.1182\/blood-2012-05-430140","journal-title":"Blood"},{"key":"1965_CR21","doi-asserted-by":"publisher","first-page":"e117","DOI":"10.1200\/JCO.2013.49.0078","volume":"32","author":"D Michonneau","year":"2014","unstructured":"Michonneau D, Kaltenbach S, Derrieux C, Trinquand A, Brouzes C, Gibault L, North MO, Delarue R, Varet B, Emile JF, Brousse N, Hermine O (2014) BRAF(V600E) mutation in a histiocytic sarcoma arising from hairy cell leukemia. J Clin Oncol 32:e117\u2013e121. doi: 10.1200\/JCO.2013.49.0078","journal-title":"J Clin Oncol"},{"key":"1965_CR22","doi-asserted-by":"publisher","first-page":"297","DOI":"10.5732\/cjc.012.10319","volume":"32","author":"SA Stacker","year":"2013","unstructured":"Stacker SA, Achen MG (2013) The VEGF signaling pathway in cancer: the road ahead. Chin J Cancer 32:297\u2013302. doi: 10.5732\/cjc.012.10319","journal-title":"Chin J Cancer"},{"key":"1965_CR23","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1111\/his.12416","volume":"65","author":"H Go","year":"2014","unstructured":"Go H, Jeon YK, Huh J, Choi SJ, Choi YD, Cha HJ, Kim HJ, Park G, Min S, Kim JE (2014) Frequent detection of BRAF(V600E) mutations in histiocytic and dendritic cell neoplasms. Histopathology 65:261\u2013272. doi: 10.1111\/his.12416","journal-title":"Histopathology"},{"key":"1965_CR24","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1182\/blood-2010-04-279083","volume":"116","author":"G Badalian-Very","year":"2010","unstructured":"Badalian-Very G, Vergilio JA, Degar BA, MacConaill LE, Brandner B, Calicchio ML, Kuo FC, Ligon AH, Stevenson KE, Kehoe SM, Garraway LA, Hahn WC, Meyerson M, Fleming MD, Rollins BJ (2010) Recurrent BRAF mutations in Langerhans cell histiocytosis. Blood 116:1919\u20131923. doi: 10.1182\/blood-2010-04-279083","journal-title":"Blood"},{"key":"1965_CR25","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1038\/35057149","volume":"409","author":"R Sachidanandam","year":"2001","unstructured":"Sachidanandam R, Weissman D, Schmidt SC, Kakol JM, Stein LD, Marth G, Sherry S, Mullikin JC, Mortimore BJ, Willey DL, Hunt SE, Cole CG, Coggill PC, Rice CM, Ning Z, Rogers J, Bentley DR, Kwok PY, Mardis ER, Yeh RT, Schultz B, Cook L, Davenport R, Dante M, Fulton L, Hillier L, Waterston RH, McPherson JD, Gilman B, Schaffner S, Van Etten WJ, Reich D, Higgins J, Daly MJ, Blumenstiel B, Baldwin J, Stange-Thomann N, Zody MC, Linton L, Lander ES, Altshuler D, International SNPMWG (2001) A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms. Nature 409:928\u2013933. doi: 10.1038\/35057149","journal-title":"Nature"},{"key":"1965_CR26","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1093\/nar\/29.1.308","volume":"29","author":"ST Sherry","year":"2001","unstructured":"Sherry ST, Ward MH, Kholodov M, Baker J, Phan L, Smigielski EM, Sirotkin K (2001) dbSNP: the NCBI database of genetic variation. Nucleic Acids Res 29:308\u2013311","journal-title":"Nucleic Acids Res"},{"key":"1965_CR27","doi-asserted-by":"publisher","first-page":"D652","DOI":"10.1093\/nar\/gkp995","volume":"38","author":"SA Forbes","year":"2010","unstructured":"Forbes SA, Tang G, Bindal N, Bamford S, Dawson E, Cole C, Kok CY, Jia M, Ewing R, Menzies A, Teague JW, Stratton MR, Futreal PA (2010) COSMIC (the catalogue of somatic mutations in cancer): a resource to investigate acquired mutations in human cancer. Nucleic Acids Res 38:D652\u2013D657. doi: 10.1093\/nar\/gkp995","journal-title":"Nucleic Acids Res"},{"key":"1965_CR28","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/j.jacc.2007.04.074","volume":"50","author":"Y Wang","year":"2007","unstructured":"Wang Y, Zheng Y, Zhang W, Yu H, Lou K, Zhang Y, Qin Q, Zhao B, Yang Y, Hui R (2007) Polymorphisms of KDR gene are associated with coronary heart disease. J Am Coll Cardiol 50:760\u2013767. doi: 10.1016\/j.jacc.2007.04.074","journal-title":"J Am Coll Cardiol"},{"key":"1965_CR29","doi-asserted-by":"publisher","first-page":"5257","DOI":"10.1158\/1078-0432.CCR-11-0379","volume":"17","author":"DM Glubb","year":"2011","unstructured":"Glubb DM, Cerri E, Giese A, Zhang W, Mirza O, Thompson EE, Chen P, Das S, Jassem J, Rzyman W, Lingen MW, Salgia R, Hirsch FR, Dziadziuszko R, Ballmer-Hofer K, Innocenti F (2011) Novel functional germline variants in the VEGF receptor 2 gene and their effect on gene expression and microvessel density in lung cancer. Clin Cancer Res 17:5257\u20135267. doi: 10.1158\/1078-0432.CCR-11-0379","journal-title":"Clin Cancer Res"},{"key":"1965_CR30","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1038\/nrclinonc.2011.69","volume":"8","author":"A Ribas","year":"2011","unstructured":"Ribas A, Flaherty KT (2011) BRAF targeted therapy changes the treatment paradigm in melanoma. Nat Rev Clin Oncol 8:426\u2013433. doi: 10.1038\/nrclinonc.2011.69","journal-title":"Nat Rev Clin Oncol"},{"key":"1965_CR31","doi-asserted-by":"publisher","first-page":"136ra170","DOI":"10.1126\/scitranslmed.3003513","volume":"4","author":"B Sen","year":"2012","unstructured":"Sen B, Peng S, Tang X, Erickson HS, Galindo H, Mazumdar T, Stewart DJ, Wistuba I, Johnson FM (2012) Kinase-impaired BRAF mutations in lung cancer confer sensitivity to dasatinib. Sci Transl Med 4:136ra170. doi: 10.1126\/scitranslmed.3003513","journal-title":"Sci Transl Med"},{"key":"1965_CR32","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1038\/nature04483","volume":"438","author":"N Ferrara","year":"2005","unstructured":"Ferrara N, Kerbel RS (2005) Angiogenesis as a therapeutic target. Nature 438:967\u2013974. doi: 10.1038\/nature04483","journal-title":"Nature"},{"key":"1965_CR33","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1096\/fj.01-0700com","volume":"16","author":"AD Laird","year":"2002","unstructured":"Laird AD, Christensen JG, Li G, Carver J, Smith K, Xin X, Moss KG, Louie SG, Mendel DB, Cherrington JM (2002) SU6668 inhibits Flk-1\/KDR and PDGFRbeta in vivo, resulting in rapid apoptosis of tumor vasculature and tumor regression in mice. FASEB J 16:681\u2013690. doi: 10.1096\/fj.01-0700com","journal-title":"FASEB J"},{"key":"1965_CR34","doi-asserted-by":"crossref","first-page":"973","DOI":"10.2174\/1568026023393273","volume":"2","author":"SJ Boyer","year":"2002","unstructured":"Boyer SJ (2002) Small molecule inhibitors of KDR (VEGFR-2) kinase: an overview of structure activity relationships. Curr Top Med Chem 2:973\u20131000","journal-title":"Curr Top Med Chem"}],"container-title":["Virchows Archiv"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-016-1965-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00428-016-1965-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-016-1965-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T15:39:56Z","timestamp":1498318796000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00428-016-1965-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,3]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["1965"],"URL":"https:\/\/doi.org\/10.1007\/s00428-016-1965-2","relation":{},"ISSN":["0945-6317","1432-2307"],"issn-type":[{"value":"0945-6317","type":"print"},{"value":"1432-2307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,3]]}}}